´ëÇÑÁ¶Çöº´ÇÐȸ Cognitive Remediation in Schizophrenia : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü
±³À°ÁÖÁ¦ : "Cognitive Remediation in Schizophrenia"
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¶Çöº´ÇÐȸ
´ã´çÀÚ : ¾ÈÀ¯¼®
¿¬¶ôó : 02-552-6677
À̸ÞÀÏ : goodpsydoc@gmail.com
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 180¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í "-»çÀüµî·Ïºñ : Æò»ýȸ¿ø ¸éÁ¦/Àü¹®ÀÇ, ±³¼ö(PHD) 50,000/Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 30,000/Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ, ´ëÇлý,´ëÇпø»ý 20,000
- ÇöÀåµî·Ï: Á¤È¸¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 60,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 40,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 30,000"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:30~11:00 Healing: Our path from mental illness to mental health (Thomas Insel, Former director, NIMH, USA) ÀÌÀ¯»ó(¿ëÀÎÁ¤½Åº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Cognitive remediation in SZ: Behavioural interventions Á¤¿µÃ¶/Á¤¼ºÈÆ(ÀüºÏÀÇ´ë/À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:40 1. Characteristics and evaluation of cognitive deficit in schizophrenia ÀÌÁß¼±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:40~12:00 2. Social cognition deficit and training in schizophrenia ¹Ú¸íÇö(´ëµ¿º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:00~12:30 3. Cognitive behavioral therapy for auditory hallucination in schizophrenia ±è¼º¿Ï(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:30~12:50 Evolving clinical management in schizophrenia with long-acting injectable antipsychotics (TBD) ±ÇÁؼö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:50~13:10 1. Recent onset schizophrenia¿¡¼ÀÇ aripiprazole Àå±âÁö¼ÓÇü ÁÖ»çÁ¦ÀÇ È¿°ú ¿À»óÈÆ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 13:10~13:30 2. Antipsychotic polypharmacy¿¡¼ÀÇ Ä¡·áÀü·«¿¡ ´ëÇØ Àå±âÁö¼ÓÇü ÁÖ»çÁ¦°¡ °®´Â ÀÌÁ¡ ¹× ÀÓ»óÀû À¯¿ë¼º ¾ÈÀ¯¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:30~15:00 Cognitive remediation in SZ: Neurobiology & Digital interventions ÀÌÇåÁ¤/À̽Âȯ(°í·ÁÀÇ´ë/ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:00~15:20 1. Detection of cognitive deficit with digital therapeutics ±èÁø¿ì(ÇÏÀÌ)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:20~15:40 2. Management of cognitive deficit with digital therapeutics ³ëÀ¯Çå(À̸ðÄÚ±×)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:40~16:00 3. Neurophysiology and cognitive remediation in schizophrenia °í¸íÁø(½Çºñ¾ÆÇコ ´ëÇ¥)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:00~16:20 Cognitive remediation in SZ: Pharmacological interventions ¾È¼®±Õ/±èÀÇÅÂ(¿¬¼¼ÀÇ´ë/¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:20~16:40 1. Antipsychotics and cognitive deficit in schizophrenia ±è¼¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:40~17:10 2. Cognitive enhancers and schizophrenia ÁÖ¼º¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 17:10~17:30 3. Medications under development for cognitive enhancement in schizophrenia ÀÌÁØÀÇ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:00~11:20 Comorbidity and differeential diagnosis of schizophrenia ¹Ú¼±Ã¶(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:20~11:40 1. Mood disorders and psychoses (ÀÌÇöÁÖ, ¼¿ïÀÇ´ë) ÀÌÇöÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:40~12:00 2. Addictive disorders and psychoses (ÃÖÁ¤¼®, ¼º±Õ°üÀÇ´ë) ÃÖÁ¤¼®(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:00~12:30 3. Neurological conditions and psychoses ±è¼º³â(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:30~12:50 Impressions from recent long acting injectable antipsychotic trials (TBD) ÀÌÁß¼(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:50~13:10 1. The best treatment practice of PPLATs to reduce relapse & rehospitalization ÀÌÁØÈñ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:10~13:30 2. How to build effective long-term treatment strategy for schizophrenic paatients in LAI treatment ÁÖ¼º¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:30~15:00 Management of tardive dyskinesia in schizophrenia ÁÖ¿¬È£/¹ÚÀÏÈ£(¿ï»êÀÇ´ë/°¡Å縯°üµ¿ÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:00~15:20 1. Neurobiology and clinical characteristics of TD ¿À»óÈÆ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:20~15:40 2. Pharmacological and nonphramacological treatment of TD Àü¸í¿í(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:40~16:00 3. Newer medications for treatment of TD: valbenazine, deutetrabenazine ±è¾ç½Ä(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:00~16:20 Á¤½Å°Ç°º¹Áö¹ýÀÇ ¹®Á¦Á¡°ú °³¼±¹æÇâ È«ÁøÇ¥/ÃÖÁØÈ£(¼º±Õ°üÀÇ´ë/ÃÖÁØÈ£)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:20~16:40 1. ÀþÀº Á¤½Å°úÀÇ»çµéÀÌ º» Á¤½Å°Ç°º¹Áö¹ý ÀÌÁ¤¼®(Àϻ꺴¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:40~17:10 2. ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸÀÇ Á¤½Å°Ç°º¹Áö¹ý °³¼±¹æ¾È ÀÌÈ¿µ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 17:10~17:30 3. Á¤½ÅÁúȯÀÚ ÀÔ¿øÁ¦µµ °³¼± ¹æ¾È ¿¬±¸ Àå¼®¿ë(¿¬¼¼´ë º¸°Ç´ëÇпø)